# Armon Sharei
En popüler podcast bölümleri
Güncellenmiş:
Top podcast episodes featuring armon sharei.
Learning Biotech, Surviving Near-Death, and Seeing What Others Don’t
Guest:Sophia Lugo
In this episode of Boba & Biotech, Sophia Lugo and I grab some delicious boba teas to explore her unconventional path into biotech and the realities of building a company at the frontier of genetic medicine. From her early experiences across Harvard, China, and the Gates Foundati…
He raised $400M for Biotech, an MIT PhD and a secret to the Roche deal.
🚀 Episode 8 of Deal Makers (& Fakers) - with Armon Sharei, Founder of Portal Bio and SQZ Biotech.
Biotech startup IPO success and raising $400M in venture capital is a dream for many founders, but what happens after you go public?
In this episode of Deal Makers (& Fakers), Niclas Schlopsna sits do…
E216: When AI meets Cell Engineering
Cell therapies have huge potential, but cost, complexity, and centralised manufacturing have kept many of them confined to last-line use. In this episode, Dr Andree Bates speaks with Armon Sharei, Founder and CEO of Portal Biotechnologies, about what happens when AI meets cell engineering, and why …
From Bench to Boardroom: What Drug Development Actually Takes
Guest: William Pao
In this episode of Boba & Biotech, Armon sits down with William Pao, a physician-scientist who has run oncology R&D at Roche, served as Chief Development Officer at Pfizer, and is now CEO and Co-Founder of Revelio Therapeutics. Few people have seen drug development from as many…
The Biotech IPO: What Bankers See That Founders Miss
Guest: Mark Dempster
In this episode of Boba & Biotech, Armon sits down with Mark Dempster, Co-Head of Healthcare Investment Banking at Stifel, to pull back the curtain on what biotech bankers actually do and why it matters more than most founders realize.
They cover the public vs. private financ…
From PhD to Public Company: Jason Kelly on Building Ginkgo and What Comes Next
Guest: Jason Kelly
In this episode of Boba & Biotech, Armon sits down with Jason Kelly, co-founder and CEO of Ginkgo Bioworks, for a conversation about what it takes to build a biotech company from scratch when no one will fund you, why platform business models in biotech are harder than they look…
Building Precision NanoSystems and the Road to a Danaher Exit
Guest: James Taylor
In this episode of Boba & Biotech, Armon sits down with James Taylor, co-founder of Precision NanoSystems, for a candid conversation about building a platform technology for nanoparticle-delivered RNA medicines from a PhD project into an 11-year journey that ended in an acquisi…
Robots, Cells, and the Future of Individualized Medicine
Guest: Fred Parietti
In this episode of Boba & Biotech, Armon sits down with Federico ("Fred") Parietti, Co-Founder and CEO of Multiply Labs, for a conversation about bringing robotics and AI into one of biotech's biggest bottlenecks: manufacturing. Fred shares how meeting his future co-founder at…
SQZ Series Part I - with Jon Gilbert Building SQZ From a Lab Bench to a Roche Deal
Backed by popular demand, we're kicking off a SQZ series on Boba & Biotech. For part I, Armon sits down with Jon Gilbert, his longtime friend and SQZ’s third employee, now leading the TuneLab effort at Eli Lilly. Taking turns as hosts, they revisit the scrappy, unpredictable early days of SQZ and u…
From the Newsroom to the C-Suite: Coaching Biotech's Best Storytellers
Guest: Mike Huckman, Principal, Huckman Group
In this episode of Boba & Biotech, Armon sits down with longtime biotech communications advisor and former CNBC reporter, Mike Huckman, to talk about one of life sciences’ biggest challenges: communicating complex science in a way that people actually …
PODCAST ARAMA MOTORU
3,830,836podcast'lerini ve196,697,213bölümlerini kişilere, yerlere veya konulara göre aramak için web sitemizi kullanabilirsiniz.
I have no special talent. I am only passionately curious, and
I listen to podcasts.
‐ Albert "Llamacorn" Einstein
DÜZENLE
Podcast veritabanını güncel tutmaya yardımcı olduğunuz için teşekkür ederiz.
